Mycobacterial susceptibility panel:-:Point in time:Isolate:Quantitative or Ordinal

Known as: Mycobacterial susceptibility panel:-:Pt:Isolate:OrdQn, Mycobacterial susceptibility panel, ?????????????:-:???:???:??????? 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2014
012319902014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND Pyrazinamide (PZA) is a first line agent for the treatment of active tuberculosis. PZA is also considered a potent… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2004
2004
Objectives-To investigate the role of humoral immunity to mycobacterial hsp65 in the aetiology of rheumatoid arthritis. Methods… (More)
  • table 1
  • table 2
Is this relevant?
2004
2004
OBJECTIVE To assess risk factors and mycobacterial agents in mycobacterial adenitis. DESIGN Cross sectional involving… (More)
Is this relevant?
Review
2004
Review
2004
Nontuberculous mycobacteria (NTM) are ubiquitous environmental organisms. In immunocompetent hosts, they are a rare cause of… (More)
Is this relevant?
1999
1999
ObjectiveFor a germicide to obtain a high level disinfection (HLD) claim, FDA requires demonstration of a 6-log reduction of… (More)
  • table 1
Is this relevant?
Review
1994
Review
1994
Mycobacterium xenopi typically accounts for less than 0.3% of all clinical mycobacterial isolates. Over a 37-mo period, 21 (35… (More)
Is this relevant?
1993
1993
To investigate whether and in which proportion normal individuals experience a priming to microbial heat shock proteins (hsp… (More)
Is this relevant?
1991
1991
The presence of mycobacteria on the skin of healthy people and in leprosy lesions has been documented previously. The present… (More)
Is this relevant?
1990
1990
We report the first year's experience of the use of a radiometric technique for sensitivity testing of mycobacterial isolates in… (More)
Is this relevant?